↓ Skip to main content

Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer

Overview of attention for article published in Journal of Ovarian Research, August 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Published in
Journal of Ovarian Research, August 2022
DOI 10.1186/s13048-022-01029-6
Pubmed ID
Authors

Xin-Ru Li, Xing-Han Cheng, Guo-Nan Zhang, Xiao-Xin Wang, Jian-Ming Huang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 11%
Student > Ph. D. Student 2 11%
Researcher 2 11%
Professor > Associate Professor 1 6%
Student > Master 1 6%
Other 0 0%
Unknown 10 56%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Biochemistry, Genetics and Molecular Biology 2 11%
Unspecified 1 6%
Veterinary Science and Veterinary Medicine 1 6%
Medicine and Dentistry 1 6%
Other 0 0%
Unknown 11 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2022.
All research outputs
#19,065,910
of 24,279,062 outputs
Outputs from Journal of Ovarian Research
#340
of 672 outputs
Outputs of similar age
#268,727
of 390,780 outputs
Outputs of similar age from Journal of Ovarian Research
#10
of 17 outputs
Altmetric has tracked 24,279,062 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 672 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 390,780 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.